Prospective observational study on the clinical relevance of the combined PET / MR examination in pediatric oncology - GK-PET/MR Tü-013

niversitätsklinikum Tübingen0 个研究点目标入组 74 人开始时间: 2021年1月19日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•Children or adolescents <18 years of age for whom the PET/MRI examination is carried out for the following indications:
•PET/MRI examination for clinical indication for tumor search (e.g. FUO)
•PET/MRI examination for clinical indication for primary staging or re-staging in Hodgin's lymphoma
•PET/MRI examination for clinical indication for primary staging or re-staging after therapy in histologically proven, advanced malignant solid tumors (e.g. bone and soft tissue tumors, CNS tumors, neuroblastomas, germ cell tumors)
•PET/MRI examination in the case of unclear or inconspicuous imaging for therapy planning (OP, RT, Ctx) and prognosis stratification
•PET/MRI examination for re-staging in neurofibromatosis type I with the question of a malignant transformation of the neurofibromas and for biopsy or surgery planning
•Written consent of the legal guardian and, if applicable, the child (depending on the individual stage of development) to participate in the study and to report so-called incidental findings after detailed explanation

•Presence of non-MRI-compatible implants or any kind of metal in and on the body (e.g. pacemakers, artificial heart valves, metal prostheses, implanted, magnetic metal parts, coils, etc.)
•Children and adolescents who report a hearing disorder or an increased sensitivity to loud noises
•Children and adolescents with reduced temperature sensation and/or increased sensitivity to warming of the body
•pregnancy
•Diabetes mellitus that cannot be controlled with medication

发起方

niversitätsklinikum Tübingen